INOVIO PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Receivable, Related Parties
INOVIO PHARMACEUTICALS, INC. (INO) reported Increase (Decrease) in Accounts Receivable, Related Parties of $2.06 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties · last filed 2022-03-01
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2021-12-31 was $210.88K, a 8434.12% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2021-09-30 was $1.63M, a 8514.29% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2021-06-30 was $375.97K.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2021-03-31 was -$156.81K.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts receivable, related parties for fiscal 2021 was $2.06M.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts receivable, related parties for fiscal 2020 was -$844.42K, a 242.29% decline from fiscal 2019.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts receivable, related parties for fiscal 2019 was $593.46K, a 135.53% increase from fiscal 2018.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts receivable, related parties for fiscal 2018 was $251.96K.
| Period end | Increase (Decrease) in Accounts Receivable, Related Parties 3 month | Increase (Decrease) in Accounts Receivable, Related Parties 6 month | Increase (Decrease) in Accounts Receivable, Related Parties 9 month | Increase (Decrease) in Accounts Receivable, Related Parties 12 month |
|---|---|---|---|---|
| 2021-12-31 | $210.88K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.84M derived: sum of 2 quarters · filed 2022-03-01 | $2.22M derived: sum of 3 quarters · filed 2022-03-01 | $2.06M 10-K · filed 2022-03-01 |
| 2021-09-30 | $1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $2.01M derived: sum of 2 quarters · filed 2021-11-09 | $1.85M 10-Q · filed 2021-11-09 | $1.85M derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-06-30 | $375.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $219.16K 10-Q · filed 2021-08-09 | $221.63K derived: sum of 3 quarters · filed 2022-03-01 | $240.57K derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-03-31 | -$156.81K 10-Q · filed 2021-05-10 | -$154.34K derived: sum of 2 quarters · filed 2022-03-01 | -$135.40K derived: sum of 3 quarters · filed 2022-03-01 | -$303.38K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-12-31 | $2.47K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $21.41K derived: sum of 2 quarters · filed 2022-03-01 | -$146.58K derived: sum of 3 quarters · filed 2022-03-01 | -$844.42K 10-K · filed 2022-03-01 |
| 2020-09-30 | $18.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$149.05K derived: sum of 2 quarters · filed 2021-11-09 | -$846.89K 10-Q · filed 2021-11-09 | -$493.39K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$167.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$865.83K 10-Q · filed 2021-08-09 | -$512.33K derived: sum of 3 quarters · filed 2022-03-01 | -$530.72K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$697.85K 10-Q · filed 2021-05-10 | -$344.35K derived: sum of 2 quarters · filed 2022-03-01 | -$362.74K derived: sum of 3 quarters · filed 2022-03-01 | -$661.54K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $353.50K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $335.11K derived: sum of 2 quarters · filed 2022-03-01 | $36.31K derived: sum of 3 quarters · filed 2022-03-01 | $593.46K 10-K · filed 2022-03-01 |
| 2019-09-30 | -$18.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$317.19K derived: sum of 2 quarters · filed 2020-11-09 | $239.96K 10-Q · filed 2020-11-09 | -$589.09K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$298.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $258.35K 10-Q · filed 2020-08-10 | -$570.70K derived: sum of 3 quarters · filed 2021-03-01 | $36.48K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $557.15K 10-Q · filed 2020-05-11 | -$271.90K derived: sum of 2 quarters · filed 2021-03-01 | $335.28K derived: sum of 3 quarters · filed 2021-03-01 | -$946.83K derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$829.05K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$221.87K derived: sum of 2 quarters · filed 2021-03-01 | -$1.50M derived: sum of 3 quarters · filed 2021-03-01 | $251.96K 10-K · filed 2021-03-01 |
| 2018-09-30 | $607.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$674.93K derived: sum of 2 quarters · filed 2019-11-12 | $1.08M 10-Q · filed 2019-11-12 | $642.96K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | -$1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $473.83K 10-Q · filed 2019-08-08 | $35.78K derived: sum of 3 quarters · filed 2020-03-12 | -$228.85K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $1.76M 10-Q · filed 2019-05-09 | $1.32M derived: sum of 2 quarters · filed 2020-03-12 | $1.05M derived: sum of 3 quarters · filed 2020-03-12 | $1.01M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | -$438.06K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$702.68K derived: sum of 2 quarters · filed 2020-03-12 | -$746.29K derived: sum of 3 quarters · filed 2020-03-12 | -$261.74K 10-K · filed 2020-03-12 |
| 2017-09-30 | -$264.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$308.23K derived: sum of 2 quarters · filed 2018-11-08 | $176.32K 10-Q · filed 2018-11-08 | $891.23K derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | -$43.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $440.94K 10-Q · filed 2018-08-07 | $1.16M derived: sum of 3 quarters · filed 2019-03-12 | $1.16M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | $484.55K 10-Q · filed 2018-05-09 | $1.20M derived: sum of 2 quarters · filed 2019-03-12 | $1.20M derived: sum of 3 quarters · filed 2019-03-12 | $1.20M derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | $714.91K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $714.91K derived: sum of 2 quarters · filed 2019-03-12 | $714.91K derived: sum of 3 quarters · filed 2019-03-12 | $714.91K 10-K · filed 2019-03-12 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $0.00 derived: sum of 2 quarters · filed 2017-11-08 | $0.00 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $0.00 10-Q · filed 2017-08-08 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-10 | |||
| 2015-12-31 | $31.63K 10-K · filed 2018-03-14 | |||
| 2015-03-31 | $0.00 10-Q · filed 2015-05-11 | $1.82K derived: sum of 2 quarters · filed 2017-03-15 | $1.82K derived: sum of 3 quarters · filed 2017-03-15 | -$16.83K derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-12-31 | $1.82K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $1.82K derived: sum of 2 quarters · filed 2017-03-15 | -$16.83K derived: sum of 3 quarters · filed 2017-03-15 | $1.82K 10-K · filed 2017-03-15 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$18.65K derived: sum of 2 quarters · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 | $0.00 derived: sum of 4 quarters · filed 2015-05-11 |
| 2014-06-30 | -$18.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $0.00 10-Q · filed 2014-08-11 | $0.00 derived: sum of 3 quarters · filed 2015-05-11 | $0.00 derived: sum of 4 quarters · filed 2015-05-11 |
| 2014-03-31 | $18.65K 10-Q · filed 2015-05-11 | $18.65K derived: sum of 2 quarters · filed 2015-05-11 | $18.65K derived: sum of 3 quarters · filed 2015-05-11 | -$24.89K derived: sum of 4 quarters · filed 2015-05-11 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | -$43.54K derived: sum of 3 quarters · filed 2015-03-16 | -$36.23K 10-K · filed 2015-03-16 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$43.54K derived: sum of 2 quarters · filed 2014-11-10 | -$36.23K 10-Q · filed 2014-11-10 | -$134.32K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | -$43.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$36.23K 10-Q · filed 2014-08-11 | -$134.32K derived: sum of 3 quarters · filed 2015-03-16 | -$33.45K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | $7.30K 10-Q · filed 2014-05-12 | -$90.78K derived: sum of 2 quarters · filed 2015-03-16 | $10.09K derived: sum of 3 quarters · filed 2015-03-16 | $4.47K derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | -$98.09K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $2.79K derived: sum of 2 quarters · filed 2015-03-16 | -$2.83K derived: sum of 3 quarters · filed 2015-03-16 | -$2.17K 10-K · filed 2015-03-16 |
| 2012-09-30 | $100.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $95.25K derived: sum of 2 quarters · filed 2013-11-12 | $95.91K 10-Q · filed 2013-11-12 | $106.07K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | -$5.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$4.96K 10-Q · filed 2013-08-09 | $5.20K derived: sum of 3 quarters · filed 2014-03-17 | -$56.98K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $660.00 10-Q · filed 2013-05-10 | $10.82K derived: sum of 2 quarters · filed 2014-03-17 | -$51.35K derived: sum of 3 quarters · filed 2014-03-17 | $13.76K derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | $10.16K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$52.02K derived: sum of 2 quarters · filed 2014-03-17 | $13.10K derived: sum of 3 quarters · filed 2014-03-17 | -$33.74K 10-K · filed 2014-03-17 |
| 2011-09-30 | -$62.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $2.94K derived: sum of 2 quarters · filed 2012-11-07 | -$43.90K 10-Q · filed 2012-11-07 | -$8.80K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $65.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $18.27K 10-Q · filed 2012-08-09 | $53.37K derived: sum of 3 quarters · filed 2013-03-18 | -$1.94M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | -$46.85K 10-Q · filed 2012-05-09 | -$11.74K derived: sum of 2 quarters · filed 2013-03-18 | -$2.00M derived: sum of 3 quarters · filed 2013-03-18 | |
| 2010-12-31 | $35.10K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$1.96M derived: sum of 2 quarters · filed 2013-03-18 | $13.30K 10-K · filed 2013-03-18 | |
| 2010-09-30 | -$1.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | -$21.80K 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | $1.97M 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | -$1.10M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |